We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » French Drugmaker Gets Warning Letter for Testing Deficiencies, Process Validation Issues
French Drugmaker Gets Warning Letter for Testing Deficiencies, Process Validation Issues
The FDA hit Biologique Recherche with a warning letter after observing multiple violations at its Paris facility, noting inadequate testing methods, quality control concerns and a lack of validation for manufacturing processes, among other issues.